Total Payments
$7,288
2024 Payments
$1,328
Companies
36
Transactions
353
Medicare Patients
10,842
Medicare Billing
$2.8M
Payment Breakdown by Category
Food & Beverage$7,212 (99.0%)
Education$76.49 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,212 | 352 | 99.0% |
| Education | $76.49 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,297 | 67 | $0 (2024) |
| PFIZER INC. | $899.26 | 43 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $660.14 | 27 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $610.40 | 34 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $471.61 | 24 | $0 (2024) |
| Lilly USA, LLC | $469.76 | 22 | $0 (2024) |
| Amgen Inc. | $368.51 | 14 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $300.19 | 13 | $0 (2024) |
| SCILEX PHARMACEUTICALS INC. | $293.09 | 13 | $0 (2024) |
| Biogen, Inc. | $266.63 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,328 | 62 | PFIZER INC. ($412.58) |
| 2023 | $1,857 | 86 | PFIZER INC. ($466.80) |
| 2022 | $1,672 | 89 | Biohaven Pharmaceutical Holding Company Ltd. ($610.40) |
| 2021 | $993.94 | 42 | Biohaven Pharmaceuticals, Inc. ($643.00) |
| 2020 | $831.18 | 43 | Novartis Pharmaceuticals Corporation ($102.35) |
| 2019 | $214.89 | 10 | Biogen, Inc. ($43.09) |
| 2018 | $209.14 | 10 | US WorldMeds, LLC ($52.93) |
| 2017 | $181.59 | 11 | Biogen, Inc. ($73.66) |
All Payment Transactions
353 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: PAIN | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.90 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 10/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Neurology | ||||||
| 10/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: PAIN | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Neurology | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: PAIN | ||||||
| 09/11/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: PAIN | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Neuroscience | ||||||
| 08/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: PAIN | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Neurology | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,587 | 56,414 | $1.6M | $719,605 |
| 2022 | 22 | 2,934 | 51,667 | $1.9M | $785,699 |
| 2021 | 22 | 2,594 | 46,430 | $1.7M | $689,056 |
| 2020 | 22 | 2,727 | 49,411 | $1.7M | $646,645 |
Total Patients
10,842
Total Services
203,922
Medicare Billing
$2.8M
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 112 | 50,600 | $694,000 | $251,346 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 468 | 1,224 | $183,650 | $94,280 | 51.3% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 222 | 224 | $95,794 | $58,824 | 61.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 131 | 133 | $70,646 | $48,071 | 68.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 227 | 507 | $69,028 | $45,278 | 65.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 225 | 250 | $71,178 | $40,113 | 56.4% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 203 | 204 | $85,384 | $40,045 | 46.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 105 | 587 | $66,484 | $35,387 | 53.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 234 | 236 | $73,859 | $34,656 | 46.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 94 | 220 | $52,452 | $33,584 | 64.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 171 | 171 | $42,750 | $24,189 | 56.6% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 11 | 19 | $7,322 | $3,780 | 51.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 47 | 63 | $6,359 | $3,029 | 47.6% |
| 93888 | Ultrasound of within the brain blood flow | Office | 2023 | 21 | 21 | $6,300 | $2,621 | 41.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 28 | $2,800 | $1,445 | 51.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,400 | $1,238 | 51.6% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2023 | 100 | 1,148 | $11,480 | $711.67 | 6.2% |
| 95992 | Repositioning exercises of head for treatment of dizziness, each day | Office | 2023 | 15 | 16 | $1,008 | $579.93 | 57.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 84 | 459 | $4,590 | $231.66 | 5.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 47 | 248 | $2,480 | $196.93 | 7.9% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 33 | 44 | $440.00 | $0.86 | 0.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 107 | 46,205 | $907,155 | $225,665 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 475 | 1,135 | $170,300 | $91,520 | 53.7% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2022 | 295 | 297 | $127,134 | $80,861 | 63.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 174 | 178 | $94,598 | $65,722 | 69.5% |
About Dr. Igor Khelemsky, MD
Dr. Igor Khelemsky, MD is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962431148.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Igor Khelemsky, MD has received a total of $7,288 in payments from pharmaceutical and medical device companies, with $1,328 received in 2024. These payments were reported across 353 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,212).
As a Medicare-enrolled provider, Khelemsky has provided services to 10,842 Medicare beneficiaries, totaling 203,922 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Brooklyn, NY
- Active Since 07/01/2006
- Last Updated 04/15/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1962431148
Products in Payments
- NURTEC ODT (Drug) $1,855
- QULIPTA (Drug) $616.24
- EMGALITY (Drug) $416.67
- UBRELVY (Drug) $409.13
- Aimovig (Biological) $368.51
- KESIMPTA (Drug) $361.65
- BOTOX (Biological) $342.13
- ZEPOSIA (Drug) $274.41
- ZTLido (Drug) $249.18
- COMIRNATY (Biological) $215.37
- TYSABRI (Biological) $188.71
- RYTARY (Drug) $184.44
- VYEPTI (Biological) $90.52
- Austedo XR (Drug) $89.77
- NASCOBAL (Drug) $84.54
- AJOVY (Biological) $71.87
- INGREZZA (Drug) $69.69
- OCREVUS (Biological) $68.74
- Seglentis (Drug) $67.65
- AUSTEDO (Drug) $62.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Neurology $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Neurology $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Neurology $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Neurology $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Neurology $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680
Neurology $96,680